Kuur Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Kuur Therapeutics M&A Summary

Kuur Therapeutics has acquired 1 company of its own.

The Company’s most targeted sectors include life science (100%).

Kuur Therapeutics Ownership

Who owns Kuur Therapeutics?

Kuur Therapeutics is owned by Athenex. It was acquired on May 4, 2021.

Kuur Therapeutics Business Overview

Where is Kuur Therapeutics headquartered?

Kuur Therapeutics is headquartered in London, United Kingdom.

What sector is Kuur Therapeutics in?

Kuur Therapeutics is a life science company.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Kuur Therapeutics

1 Canal Side Studios, 8-14 St., Pancras Way,
London, NW1 0QG
United Kingdom,
+44 (0)20 7554 4070
www.kuurtx.com

Kuur Therapeutics is a developer, manufacturer, and marketer of cellular immunotherapy products for the treatment of cancer and infections. Kuur Therapeutics’s lead oncology product, baltaleucel-T, is aimed at a range of cancers associated with the oncogenic Epstein Barr virus (EBV), including non-Hodgkin lymphomas, Hodgkin lymphoma, and nasopharyngeal carcinoma. Kuur Therapeutics is based in London, United Kingdom.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Delenex Therapeutics AG 2016-07-12 - Add-on Acquisition
Schlieren, Switzerland · www.delenex.ch
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
Switzerland 1 - - -
Total 1 - - -

Company Summary

SECTOR

Life Science

Former Name

Cell Medica

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Kuur Therapeutics

Life Science Companies , United Kingdom Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United Kingdom Companies

Largest United Kingdom Companies , Acquisitive United Kingdom Companies , Recently Acquired United Kingdom Companies , Recently Sold United Kingdom Companies , Private United Kingdom Companies , Public United Kingdom Companies , Acquired United Kingdom Companies , PE Backed United Kingdom Companies
Mergr

Product

Company

Legal